Thursday, October 29, 2026

IPO Bound Sarva Foam Industries announces £6 Million Investment in Scotland




Proposed manufacturing facility to support sustainability, resource recovery along with Scotland and India trade ties

Mumbai, October 29, 2026: Sarva Foam Industries Limited (“Company”), has announced a planned investment of £6 million in Scotland to establish a new manufacturing facility, marking the first phase of its proposed expansion in Scotland.

The announcement was welcomed by Scotland’s First Minister, John Swinney, during his visit to Sarva Foam’s office. The proposed investment reflects the Company’s focus on expanding/ building its manufacturing presence and supply chain in Europe and help mitigate risks such as geopolitical uncertainties, supply chain bottlenecks and high transportation costs thereby driving greater operational efficiency and cost optimization in markets outside India and strengthening economic ties between India and Scotland.

Mr. Kunal Giani, CMD, Sarva Foam Industries said, “We are planning to establish a foam-recycling manufacturing operation in Scotland, with an initial investment of approximately £6 million. Drawing on our manufacturing expertise, the operation would turn discarded foam into carpet underlay and flooring products, keeping materials out of landfill and contributing to Scotland’s circular economy and net zero goals. If the first phase succeeds and the broader commercial and funding arrangements are confirmed, total investment could reach up to £12 million over three years, with the potential to generate up to 100 jobs in Scotland, including skilled manufacturing positions. Deloitte is advising the Company on inorganic growth initiatives and is helping shape and advance this potential investment. We discussed this opportunity with the First Minister and will continue working with Scottish Enterprise to deliver the project.

Mr. John Swinney, The First Minister, Scotland, added, “This planned investment from Sarva Foam is a fantastic example of how Indian capital can help drive growth, build prosperity and create jobs in Scotland. Given the focus on using a circular economy model and utilising used materials, the new facility will also contribute to our ambitions to support green, sustainable jobs as we move towards net zero. Bolstering trade and investment relationships with India offers a golden opportunity for a wide range of Scottish businesses and for Scotland’s economy. Our strengths in technology, financial services and clean energy – make us uniquely placed to match India’s priorities for investment. Our own independent analysis showing Scotland and India’s trading partnership could be worth more than £3 billion a year by 2030.”

 

The proposed investment represents an opportunity to deepen collaboration between Indian industry and Scotland’s manufacturing ecosystem, creating avenues for long-term growth, sustainable production and cross-border business partnerships.

About the Sarva Foam Industries Limited
Incorporated in 2018, the Company is a specialized manufacturer and trader of rebonded polyurethane (PU) foam, operating a circular-economy business model that converts PU foam trims and off-cuts into value-added rebonded foam products. We are the largest rebonded Polyurethane (PU) Foam player in India (with an estimated market share of around 33% (FY 2026) and also the largest exporter of rebonded PU foam products in India. (Source: D&B Report)

 

The Company operates under three product segments: (i) Rebonded Foam Sheets which are precision-cut sheets for mattresses, furniture and flooring; (ii) Rebonded Foam Blocks which are high-density engineered blocks for industrial conversion and (iii) Rebonded Carpet Underlays which are continuous rolls for carpet, sports & acoustic flooring.

 

The Company operates out of its four existing strategically located manufacturing facilities with one unit in Dadri, Uttar Pradesh (Northern India), one unit in Silvassa, Dadra & Nagar Haveli (Western India) and two units in Krishnagiri, Tamil Nadu (Southern India). Its aggregate manufacturing capacity as of March 31, 2026 is 15,500 metric tonnes per annum.

From Aragonda to a Healthier India: Apollo’s Total Health Model Demonstrates How Rural Healthcare Can Transform Lives



From a rural hospital to a model for integrated community development, Apollo Foundation's initiatives have impacted over 483 million people through healthcare, education, nutrition, livelihoods and other essential services

Aragonda, Andhra Pradesh, October 29, 2026 – Demonstrating how healthcare can become a catalyst for community transformation, Apollo Hospitals Enterprise Limited (AHEL) and Apollo Foundation today celebrated the impact of the Total Health model in Aragonda, in Andhra Pradesh’s Chittoor district. What began with a rural hospital has evolved into an integrated approach to community development, bringing together healthcare, preventive health, education, nutrition, safe drinking water, skill development and livelihood opportunities to impact over 483 million people.

Launched by Apollo Foundation in Aragonda in 2013, Total Health, a CSR initiative of AHEL, extends Apollo’s vision of healthcare beyond clinical care to address the wider determinants of lifelong wellbeing. The initiative has since expanded to over 23 geographies, delivered more than 2 lakh yoga training sessions, and served over 10.89 lakh meals through its nutritious meal programme over the 13 years since its inception. It has also enabled rural employment for over 300 women through textile and jute production units.

Ms. Upasana Kamineni Konidela, Vice Chairperson – CSR and Director – Projects, Apollo Hospitals Enterprise Ltd., said, “Aragonda has shown that lasting health outcomes are created beyond the walls of a hospital. The transformation we have witnessed here demonstrates how integrated, community-led healthcare models can create sustainable change and serve as a blueprint for replication across other states and underserved regions.”

Commenting on the journey, Dr. Prathap C. Reddy, Founder Chairman, Apollo Hospitals Group, said, “Aragonda is where my journey began, and it has always strengthened my belief that quality, affordable healthcare must reach every Indian, regardless of where they live. We began by bringing modern medicine to this village. But the true promise of healthcare lies beyond treating disease – in creating conditions for people to flourish. Medicine can save lives, but to change the health of a generation, we must also change the conditions in which life is lived. I believe Aragonda will stand for an idea larger than itself: that a healthier India will be built not only in its great cities, but in its smallest villages.”

Building Healthier Communities, Beyond Healthcare
Apollo Foundation works through its various arms and partners, including Total Health, Billion Hearts Beating Foundation, Apollo Telemedicine Networking Foundation, SACHi and Aragonda Vikas Trust, to deliver a range of community-focused interventions. These span primary healthcare, diagnostics, telemedicine, mobile medical services, cancer screening and access to treatment, as well as free heart surgeries and lifelong follow-up for children.

Ms. Preetha Reddy, Executive Vice Chairperson, Apollo Hospitals Enterprise Ltd., added, “Over the past two decades, Apollo Hospitals Aragonda has demonstrated that the impact of healthcare extends far beyond clinical care. Through its pioneering model, the hospital has not only improved health outcomes but also enabled women to access livelihoods, strengthened families and enabled communities to take ownership of their wellbeing.”
Dr Sangita Reddy, Joint Managing Director, Apollo Hospitals said, “India’s next healthcare revolution will not be measured by how many hospitals we build, but by how many illnesses we prevent and how many healthy years we add to people’s lives. Aragonda is our living blueprint for that future—where technology, prevention and community empowerment come together to make world-class healthcare accessible to every Indian, regardless of their pin code.”
Livelihood generation is another key pillar of Total Health. Through apparel and jute production units in Aragonda, Amrabad and Chevella, the programme promotes women's economic independence. In the past year alone, around 300 women working through these units produced nearly 2.9 lakh jute bags and over 1.25 lakh pieces of clothing.


Bringing Orthopaedic Care Closer to Home: 1,000 Knee Replacements in Aragonda

Driven by his conviction that world-class healthcare should not remain confined to large cities, Dr. Prathap C. Reddy, Founder Chairman of the Apollo Hospitals Group, established a 50-bed secondary care hospital in Aragonda, his birthplace, in 2000. Twenty-six years later, Apollo Hospitals Aragonda has served more than 1.67 lakh patients and completed over 12,000 surgeries, including a milestone of 1,000 total knee replacement (TKR) surgeries. The achievement underscores how advanced healthcare can be made accessible to rural communities, reducing the need for patients to travel to distant cities for specialised treatment.

The hospital's total knee replacement programme has grown steadily, from 100 procedures in 2019 to 500 in 2022 and now 1,000. Its clinical capabilities were further demonstrated by the completion of 19 knee replacement surgeries in a single day, led by Dr. Madan Mohan Reddy, Dr. Vijay Kishore Kondreddy, Dr. Kunal Patel and the wider clinical team.
Dr. Jayapal (Anil) Reddy, Clinical Associate Professor, Section of Cardiology, California University of Science and Medicine, said, “Apollo Hospitals Aragonda is a powerful example of the ‘Heal in India’ vision, proving that world-class healthcare does not have to be limited by geography. It is now ready for the world. As a physician practising in the United States and a native of Aragonda, I take pride in seeing advanced surgery, critical care, emergency services and diagnostics available in my own village. Dr. Prathap C. Reddy’s vision has created not just a hospital, but an enduring healthcare legacy for generations.

About Apollo Hospitals Enterprise Ltd.
In 1983, Dr. Prathap C. Reddy founded Apollo Hospitals in Chennai with a vision to strengthen India’s healthcare capabilities and bring advanced medical care closer to the people who need it. Since then, Apollo has expanded its presence across hospitals, pharmacies, clinics, diagnostic centres and telemedicine services. Its network includes over 10,400 beds across 76 hospitals, 7,113+ pharmacies, 308 clinics, 2,457 diagnostic centres and 800+ telemedicine centres. Apollo has performed over 300,000 angioplasties and 200,000 cardiac surgeries. The organisation continues to invest in research and innovation and in the adoption of advanced medical technologies and treatment options, with the aim of expanding access to specialised healthcare for patients across India and beyond.

About Apollo Foundation – Total Health
Established in Aragonda, Andhra Pradesh, in 2013, Total Health is Apollo Foundation’s integrated community development initiative. Working across health and hygiene, community engagement and alternative livelihoods, it addresses the physical, mental, social, ecological and economic factors that influence wellbeing. The programme aims to develop sustainable, scalable and accountable models that enable communities to become healthier, more resilient and self-reliant.

ITC Maratha Presents Its Diwali Gifting Collection with Ritvah


This Diwali, ITC Maratha presents its Ritvah gifting collection, bringing together a range of festive offerings for the season. Featuring traditional mithai, artisanal treats, chocolates, and festive keepsakes, the collection offers thoughtful gifting options for family, friends and business associates.

With a variety of hampers available, the collection brings together a selection of festive favourites and indulgent treats.

The Legacy Collection – ₹23,999

The Legacy Collection features Ritvah’s Signature Mithai Box of 24, a Legacy Hamper comprising three varieties of Nankhatai, Festive Jar Treats featuring Dark Chocolate Coated Almond Dragees, Lime and Pepper Roasted Cashews and Blueberry Dragees, and Festive Nut & Seed Clusters in two variants. The hamper also includes a Fabelle Dessert Collection Box of 20 Truffles, a hand-crafted Pooja Set in a Glass Diffuser and Candle Set, an Ishka Gift Set of Caper Mustard and Capers, a Glass Tealight Set of 2, a Special Tea Blend and a Mangaldeep Diya.

The Grand Curation – ₹8,199

The Grand Curation brings together Ritvah’s Signature Mithai Box of 24, Festive Tea Cake and Festive Nut & Seed Clusters in a set of two jars. The selection is complemented by a Fabelle Luxury Chocolate Bar in Tiramisu flavour and a Cobalt Blue Diamond Cut Tea Light Votive.

The Festive Reserve – ₹3,299

The Festive Reserve features Ritvah’s Signature Mithai Box of 24, along with Festive Jar Treats comprising Hazelnut Chocolate & Seed Granola and Dark Chocolate Coated Almond Dragees. A Soy Wax Candle completes the hamper.

With its range of festive offerings, Ritvah at ITC Maratha brings together a selection of traditional sweets, contemporary indulgences and thoughtful keepsakes for Diwali gifting.

For details or orders, please call 02261841818
Images: https://drive.google.com/drive/folders/14W_dSK_L_jwY8jkx6YES2zSFAfBk1a4l?usp=drive_link

Wednesday, October 28, 2026

Bank of India and C-DAC sign MoU to Advance Quantum Financial Innovation and Emerging Technology Adoption


 (Shri Satyendra Singh , CGM IT & CIO, Bank of India signing MoU ) 
 Collaboration to focus on translating indigenous quantum technologies into 
practical banking applications
 Priority areas include quantum-safe security, digital signatures, quantumgenerated randomness and advanced optimization
 MoU also provides a framework for collaboration in Artificial Intelligence, 
Blockchain, cybersecurity and other emerging technologies
 Joint research, Proofs of Concept (PoCs), technology demonstrations and 
capacity building to support future-ready banking
 Partnership brings together Bank of India’s banking expertise and scale with CDAC’s capabilities in advanced computing and indigenous technology 
development
New Delhi, October 22, 2026: Bank of India (BOI) and the Centre for Development of 
Advanced Computing (C-DAC), an autonomous scientific society under the Ministry of 
Electronics and Information Technology (MeitY), Government of India, today signed a 
Memorandum of Understanding (MoU) to collaborate on quantum financial innovation and 
the adoption of emerging technologies in banking.  
The MoU establishes a framework for Bank of India and C-DAC to explore joint research, 
development, pilot implementations, technology demonstrations and capacity-building 
initiatives across technologies of strategic relevance to the banking and financial services 
sector. 
The collaboration brings together Bank of India’s banking domain expertise, nationwide 
presence and high-volume technology environment with C-DAC’s capabilities in High 
Performance Computing, Artificial Intelligence, Quantum Technologies, Blockchain, 
Cybersecurity and indigenous technology development. 
A key focus of the partnership will be the development of a Quantum Ecosystem for 
Financial Innovation, aimed at preparing banking systems for the opportunities as well as 
emerging security challenges associated with quantum technologies. The two organizations 
will jointly explore quantum-inspired and quantum-safe technologies that can strengthen 
security, trust, resilience and decision-making in banking. 
The collaboration will seek to identify a prioritized portfolio of banking use cases, 
demonstrate Proofs of Concept in secure sandbox environments, assess technical feasibility 
and potential banking value, benchmark emerging approaches against existing systems, and 
develop roadmaps for further development, pilots or adoption. 
Commenting on the collaboration, Shri Rajiv Mishra, Executive Director, BOI, said, 
“Quantum technologies have the potential to reshape several aspects of banking, from 
cybersecurity to complex financial decision-making. Through our collaboration with C-DAC, 
we aim to explore and evaluate these emerging possibilities in a structured manner, while 
building the knowledge and capabilities required to prepare Bank of India for the next 
generation of technology” 
Shri S. Krishnan, Secretary IAS, MeitY, congratulated Bank of India for its contribution to 
technological advancement and appreciated its collaboration with C-DAC to foster 
indigenous innovation. He emphasised the need to build a quantum-resilient financial 
ecosystem in an era of growing cybersecurity concerns and emerging technological threats, 
preparing the banking sector for the challenges and opportunities of the quantum era. 
Commenting on the MoU, Shri E. Magesh, Director General, C-DAC, said, This collaboration 
with Bank of India is an important step towards translating India’s indigenous quantum and 
emerging technology capabilities into practical banking solutions. Through joint research 
and development and capacity building, C-DAC aims to support a secure, resilient and futureready financial ecosystem. 
Beyond quantum technologies, the MoU provides a framework for collaboration in 
Blockchain, Artificial Intelligence and other emerging technologies relevant to 
financial services. Potential areas include intelligent document processing, customer and 
employee assistance, fraud analysis, credit and financial analytics, secure AI platforms, responsible AI, smart contracts, digital identity, secure data sharing and other applications 
relevant to banking. 
The partnership will also focus on developing a future-ready talent ecosystem through 
training and capacity-building programmes in areas including Quantum Computing, 
Quantum Security, Artificial Intelligence, Blockchain and other emerging digital technologies. 
The MoU was formally exchanged by Shri Aditya Kumar Sinha, Executive Director, C-DAC 
Mumbai and Shri Satyendra Singh , CGM IT & CIO, Bank of India , in the presence of Shri 
S. Krishnan, IAS, Secretary, MeitY; Shri Rajiv Mishra, Executive Director, Bank of India, 
Shri Sudeep Shrivastava, Joint Secretary, MeitY, Shri E. Magesh Director General C-DAC,
along with other senior officials from MeitY, Bank of India and C-DAC. 
Through the collaboration, Bank of India and C-DAC Mumbai aim to create a structured 
pathway for translating indigenous research and emerging technologies into practical 
banking applications, while contributing to a secure, resilient and technologically future-
ready financial ecosystem.

Monday, October 26, 2026

Aptech Limited and Film and Television Institute of India (FTII) Enter into Partnership to Democratise Access to Film and Creative Education Across India




~Strategic collaboration to offer workshops, certified programmes and a co-developed filmmaking programme, combining FTII’s cinematic expertise with Aptech’s industry-oriented skilling ecosystem~

National, October 26, 2026: Aptech Limited, a pioneer in vocational training and global learning solutions has entered into a collaboration with The Film and Television Institute of India (FTII) to expand access to quality film education and creative skills across India.

The partnership brings together FTII’s academic excellence and rich cinematic legacy with Aptech’s 30+ years of experience in vocational education across Media & Entertainment, creative careers and the AVGC-XR ecosystem, backed by its expertise in curriculum development and established extensive training network. Together, the institutions will create structured, industry-relevant learning programs for aspiring filmmakers, content creators, animators, VFX professionals and other creative talent, enabling learners to build the skills, creative capabilities and practical exposure needed to thrive in the rapidly evolving Media & Entertainment and AVGC-XR sectors. The collaboration will offer learners access to FTII-led learning experiences through Aptech’s ecosystem, while creating learning opportunities that range from focused workshops and micro-credentials to specialised certification and an immersive, co-developed filmmaking programme.

The partnership will be executed through three distinct engagement models creating multiple routes to creative learning. 

1. FTII Workshops & Micro-Credentials
Under the first model, selected FTII workshops will be made accessible to eligible students at Aptech centres. The workshops will provide learners with opportunities to engage with specialised areas of filmmaking and cinematic storytelling, enabling them to complement their existing learning with focused, expert-led interventions from FTII. Eligible participants will receive applicable FTII certificates or micro-credentials, creating opportunities for learners to build specialised knowledge and demonstrate additional competencies.

2. Aptech–FTII Joint Certification Programme
The second model will integrate a two-month FTII module with Aptech’s training brands offering VFX and 3D programmes. The programme will combine existing structured, industry-oriented training with FTII’s academic and cinematic expertise, giving learners exposure to advanced filmmaking concepts and practices. Successful students will receive a joint certificate, subject to meeting the prescribed programme and certification requirements. The model is designed to strengthen the bridge between technical skills and cinematic application, enabling students to develop a more holistic understanding of visual storytelling.

3. Co-Curated Joint Certification Programme
The third and most comprehensive model will be a co-developed programme, including a two-month immersive learning experience at the FTII campus in Pune. Initially planned across Aptech’s own centres in Mumbai, Pune and Bengaluru, the programme will combine structured learning at Aptech’s training centres with intensive academic immersion and mentorship at FTII. A key outcome of the programme will be the opportunity for students to produce a short film under FTII mentorship, allowing them to translate classroom learning into an actual creative project. The programme will also facilitate exposure to internships and industry associations, helping students build practical capabilities and a stronger portfolio as they prepare for careers in the Media & Entertainment industry.

Mr. Sandip Weling, Whole-time Director & Chief Business Officer, Global Retail, Aptech Limited, said, “The future of creative education lies in bringing together strong academic foundations, industry-relevant skills and opportunities for experiential learning. Our collaboration with FTII brings together two complementary strengths- FTII’s unparalleled cinematic legacy and Aptech’s expertise in vocational education and nationwide delivery. Through these three models, we aim to give learners greater access to specialised knowledge, mentorship and real-world creative experiences, ultimately enabling them to build stronger capabilities, portfolios and career pathways in the Media & Entertainment and AVGC-XR ecosystem.”

Mr. Santosh Ojha, Head of Strategy, FTII, added, “FTII has a rich legacy of nurturing filmmakers and storytellers, and we believe this learning should reach many more aspiring creative professionals. Our collaboration with Aptech gives us the opportunity to take FTII’s academic and cinematic expertise beyond our campus, leveraging Aptech’s extensive network of creative education centres across India. Cinema is as much about storytelling, imagination and creative expression as it is about technical skills. Through this association, we hope to bring that perspective to more learners through specialized programmes, workshops and hands-on experiences, helping shape the next generation of filmmakers and creative professionals.”

Mr. Abir Aich, Executive Vice President, Aptech Limited, said, “One of the key objectives of this collaboration is to bring the art and practice of filmmaking closer to students pursuing careers in the creative industry. By combining Aptech’s technology and production-focused learning with FTII’s expertise in cinema and storytelling, we want to help students develop a more rounded understanding of how films and visual content are actually created. Importantly, this opportunity will be available to both new and existing students, giving them access to specialized learning, industry mentorship, and internship opportunities to work on projects. For the industry, we believe this can help build a ready pool of future creative talent, who bring together technical proficiency, cinematic understanding and practical filmmaking skills, and are better prepared to contribute from the outset.”

The partnership aims to move beyond conventional skill training towards applied, experiential and outcome-oriented creative education, equipping learners with the technical proficiency, storytelling capabilities, creative thinking and industry exposure needed to succeed in the evolving Media & Entertainment and AVGC-XR sectors. This may also lead to internship opportunities for the top talent. Through three progressive learning models from specialised workshops and micro-credentials to integrated certification and immersive filmmaking the collaboration seeks to expand access to quality creative education and build a future-ready talent pool for India’s growing creative economy.



ABOUT APTECH LIMITED
With over three decades of strong experience in the vocational skill training and non-formal academic curriculum-based training programs, Aptech Limited is a pioneer in the non–formal vocational training business in the country with a significant global presence. Ever since its commencement in 1986 and with a current presence of over 750 centres globally, Aptech Limited has effectively ventured into diverse sectors ranging from IT training, media & entertainment, virtual production, beauty & wellness, retail & aviation, pre-school segment, amongst others. Aptech Limited has successfully trained students, professionals, universities & corporates through its two main streams of business- Individual training and Enterprise Business Group. 

Under Individual Training, Aptech offers career and professional training through its multi-brands- Arena Animation & Maya Academy of Advanced Creativity (both in Animation & Multimedia), Lakmē Academy powered by Aptech (beauty & grooming), Aptech Aviation & Hospitality Academy, Aptech Learning, and Aptech International Pre-school, amongst others.

Enterprise business includes Training and Assessment Solutions for Corporates & Institutions (Aptech Training Solutions, Aptech Assessment & Testing Solutions). Aptech Limited has been recognized as a 

Great Place to Work (2017 & 2019) won the Golden Peacock National Training Award (2019) and appraised at Maturity Level 5 of People Capability Maturity Model (PCMM) in the year 2020. For further information please visit- https://www.aptech-worldwide.com/

About FTII: 

The Film and Television Institute of India (FTII) was set up by the Government of India in 1960, in the premises of the erstwhile Prabhat Studios in Pune.

Today, FTII is recognised as a centre for excellence in audio visual media across the world and one of the best film institutes in India. FTII alumni work everywhere: from Los Angeles, Paris, and London to Mumbai, Hyderabad, Trivandrum, Chennai, and Kolkata. Over the years they have gained popularity and have earned various laurels as accomplished technicians and superstars. The alumni have also won popular film and television awards from the ‘National Film Awards’ to ‘Oscars’, to the ‘Dada Saheb Phalke award’ to the prestigious ‘Padma Awards’.

Leading brokerage gives thumbs up to EAAA India Alternatives Limited IPO*

*Leading brokerage gives thumbs up to EAAA India Alternatives Limited IPO*
_Only alternatives platform in India to have a diversified suite of Yield & Income Solutions to domestic and global investors with Asset Under Management (“AUM”) of ₹ 953.45 bn_

Leading brokerage firms Anand Rathi, Bajaj Broking, GEPL Capital and Ventura Securities have given their "Subscribe" recommendation to EAAA India Alternatives Limited, which is one of the leading alternative platforms in India, in terms of assets under management (AUM) with more than 17 years of experience (Source - CARE Report) of managing long term patient capital with an AUM of Rs 953,448.78 million or Rs 95,344.8 crore, as of June 30, 2026.

Anand Rathi highlights the company is an alternative investment management platform focussed on Indias real assets and private credit markets. On the valuation front, at the upper price band, the company is valued at a PE of 40.6 times FY26 and 33.2 times FY26 EV / EBITDA. Given its leadership position in India's alternatives market, diversified investment platform, strong growth in FPAUM, robust profitability metrics and favourable industry outlook Anand Rathi recommends subscribe for Long Term to the issue.

GEPL Capital highlights the company’s wholly owned subsidiary, Sekura India Management, supports asset operations, maintenance, monitoring, and efficiency improvement. On the valuation front, based on FY26 earnings, the issue is priced at a PE of 33. GEPL recommends subscribe to the issue.

Bajaj Broking highlights the company is an alternative investment management platform focussed on Indias real assets and private credit markets. On the valuation front, the company is valued at a PE of 40 based on FY26 earnings. Bajaj Broking recommends subscribe to the issue.

Ventura Securities Ltd giving subscribe recommendation to the IPO highlights, EAAA India Alternatives has delivered healthy growth in recent years, supported by rising alternative investment allocations and expansion in its fee-paying asset base. Revenue from operations increased from INR 492.6 crore in FY24 to INR 670.3 crore in FY25 and INR 869.5 crore in FY26, while PAT increased from INR 175.2 crore to INR 229.8 crore and INR 265.2 crore, respectively. Total AUM increased from INR 54,679 crore in FY24 to INR 59,629 crore in FY25 and INR 72,706 crore in FY26, before rising further to INR 95,345 crore as of June 2026. In FY26, EBITDA excluding other income stood at INR 323.3 crore, translating into an EBITDA margin of 37.2%, while PAT margin stood at 30.5%, reflecting the asset-light and fee-driven nature of the business.

EAAA India Alternatives IPO is open for subscription and closes on October 28, 2026. The price band is kept at Rs 1585 per equity share to Rs 1665 per equity share, and the Investors can bid for a minimum of 9 Equity Shares and in multiples of 9 Equity Shares thereafter.

*Dr. Niyati Mahesh Mhatre Achieves Milestone, Officially Earning Master of Surgery in Obstetrics & Gynaecology*




MUMBAI / PUNE — In a proud and inspiring milestone for aspiring healthcare professionals, Dr. Niyati Mhatre has officially completed her post-graduate medical specialization, earning her Master of Surgery (MS) degree in Obstetrics and Gynaecology (OBGY).
The achievement marks the culmination of years of rigorous clinical residency, academic dedication, and front-line maternal healthcare service.
Obstetrics and Gynaecology is widely recognized as one of the most demanding clinical disciplines in modern healthcare, requiring round-the-clock emergency obstetric care, surgical acumen, and compassionate patient handling. Throughout her training, Dr. Mhatre actively engaged in bedside patient management, labour room duties, and critical neonatal transitions.
Family members, colleagues, and well-wishers took to social media to celebrate her success, expressing heartfelt emotions over her journey. "Today is one of the proudest days of our lives. Seeing you becoming MS OBGY and living your dream is a blessing beyond words," read a tribute shared in her honour.
With maternal health and specialized women’s healthcare remaining top priorities in India's medical sector, the induction of dedicated young specialists like Dr. Niyati Mhatre reinforces the standard of care available to mothers and newborns alike.

Friday, October 23, 2026

RoyalSandurforaysintoMedicalDevicesandConsumables;RoyalSandur


MedTechleaseslandatAndhraPradeshMedTechZone,Visakhapatnam
The SandurManganese & IronOres Limited (‘SMIORE’ or ‘the Company’), the flagship companyof the Royal Sandur Group,has taken a decisive step towardsits forayinto the Medical Devices and Consumables business. Royal SandurMedTech Private Limited, awholly owned subsidiary of the Company,has taken land on a long-term lease at the Andhra Pradesh MedTech Zone (‘AMTZ’), Visakhapatnam,India’spremiermedicaltechnologyparkwithcommonmanufacturingfacilitiesand scientific facilities.
Theleasedeedwas executedon 19October 2026between Royal Sandur MedTechPrivateLimited and Andhra PradeshMedTech ZoneLimited, theGovernment ofAndhraPradeshundertaking that owns and operates AMTZ, for setting up a manufacturing unit atAMTZ. Royal Sandur MedTech Private Limited has also taken office space at World Trade Center AMTZ to support project development. Key terms of the land lease are as follows:
Developedlandmeasuring6.2 acres(about25,090square metres),withroad,power,water and effluent infrastructure provided by AMTZ
Leasetenure of33 yearsfrom thedateof execution, withan exclusiveright toconvertthe leaseholdrights intofreeholdownershipafter 10 yearsfromthedateofcommissioningof business
This marks a concrete move by SMIORE towards new frontiers, as partof itscomprehensive diversificationstrategy.Furtherdetailsonthe capitalexpenditureplansandprojecttimelineswill be announced in due course.
Commentingonthedevelopment,BahirjiA.Ghorpade,ManagingDirector,SMIORE,said:
“Our diversification strategy is about building new engines of growth alongside our core mining and metals businesses. Medical Devices and Consumables sector offers considerable opportunities for domestic manufacturing to grow, and the Andhra Pradesh MedTech Zone, with its common manufacturing and scientific facilities, gives a new entrant the right platformtobuildcapabilities in a focused and capital-efficient manner. Securing this land is the first concrete step in this journey, andwe intend to pursue it with the same discipline that has defined our enterprise over seven decades.”
Welcoming Royal SandurMedTechto theecosystem,Dr. JitendraSharma, ManagingDirector & Founder CEO, Andhra Pradesh MedTech Zone (AMTZ), said:
“We were pleased to welcome Royal Sandur MedTech to the AMTZ ecosystem. Their investment reflected the growing confidence of Indian industry in the nation’s medical technology manufacturing capabilities and reinforced AMTZ’s role as a catalyst for innovation, indigenous manufacturing, and globalcompetitiveness. Such collaborations continue toaccelerateIndia’s journey towards becoming a global hub for medical technology manufacturing and healthcare innovation.”



AboutTheSandurManganese &IronOresLimited
The Sandur Manganese& Iron Ores Limited(“SMIORE”) isoneofIndia’smost respected private sector merchantminers and commodity producerswithan operational track record spanning over seven decades. At present, the Company’s operations span over three business segments i.e., Mining(Manganese & Iron Ores), Ferroalloys, and Coke and Energy. Further, the Companyhas presence in specialty steel sector through its material subsidiaryRoyal Sandur Metals Private Limited, which is the leading independent SBQ players in the country. Together, these assets work in conjunction with eachother to leverage the benefits of being anintegrated Company.
AboutRoyalSandurGroup
AsSMIORE’s operationshavegrown acrossmining,ferroalloys, cokeandenergy, andsteel,the Companyhasadopted a unified Groupbrand name, ‘RoyalSandurGroup’, andits logo, to supportits long-termstrategic visionandenableit to explorediversebusinessopportunities.Thename carriesforward theCompany’s royal heritage and its enduring bond with Sandur, built over seven decades of enterprise. Under thisunified banner, each business entityretains its own focus while contributing to one corporate identity, presenting the organisation to customers, investors and communities as a single,integratedgroup.

Sahajanand Medical Technologies Limited’s IPO listed at Rs 371.15 on the exchange, reaches a high of Rs 409.95




Mumbai - October 23, 2026: Shares of Surat-based Sahajanand Medical Technologies Limited, the Company has built a strong clinical foundation for its flagship products – Supraflex Cruz, Hydra, Sironity Drug-coated PTCA Balloon, Pipit and Cocoon, supported by 75 clinical studies (comprising 66 completed studies and 09 ongoing studies), as of June 30, 2026, across diverse geographies and patient populations was listed at Rs 368.05 on the BSE with a premium of 7% to the IPO price.
The scrip reached a high of Rs 409.95 on the NSE, and Rs 409.95 on the BSE.
The scrip closed at Rs 377.65 on the NSE and Rs 375 on BSE.
As per NSE, the total quantity traded stood at 13.02 lakh shares, on BSE the total Quantity stood at 174 lakh shares. Total Turnover (BSE+NSE) on Day 1 stood at Rs 709.55 crore.
The Market Capitalisation of the Company at today’s closing price stood at Rs 3,844.28 crore as per BSE and Rs. 3,838.69 crore as per NSE.
The issue received bids of 13,84,72,771 equity shares against the offered 97,50,482 equity shares, according to data available on the stock exchanges.
Qualified Institutional Buyers (QIB) and Retail Portion were subscribed 34.70 times and 3.03 times, respectively. Non-Institutional Investors (NII) portion was subscribed 14.64 times whereas the employee reserved portion subscribed 0.37 times.
About the Company
The Company was formed as a partnership firm in 1999, and thereafter incorporated as a joint stock company in 2001. The Company is a Class III and Class C/D medical devices company with a portfolio of technologically advanced medical devices across vascular and structural heart intervention. According to the report titled “Independent Market Research on Cardiovascular Devices Market” dated September 30, 2026, prepared and released by Frost & Sullivan (the “F&S Report”), the Company was the first in the world to receive a CE certification for a DES with a biodegradable polymer- based paclitaxel-eluting stent (Infinnium). Over the years, the Company has introduced several innovative products, driven by its focus on research and development and precision manufacturing capabilities enabling it to deliver quality products backed by clinical data, with a presence across 65 countries including India in the three months ended June 30, 2026 and 77 countries including India in Fiscal 2026.
It is a R&D-driven company engaged in the development of Class III and Class C/D medical devices, with an emphasis on vascular intervention (VI) and structural heart (SH). Its portfolio of VI products includes coronary intervention products such as coronary stents and coronary balloons, SH products include TAVI and occluders, and others including its own brand of renal stents, peripheral DCBs and other trading products.

Wednesday, October 21, 2026

Flipkart’s Big Billion Days Brings in More Users and Orders, with Buyer Growth Across Categories


Orders, units and buyers each grew about 20%-22% over last year
About 9 in 10 of India’s online shoppers visited Flipkart during the sale
Unique visitors up nearly 10%
Beauty, Grooming and General Merchandise buyers up 40%
Bengaluru, October 21, 2026: The Big Billion Days opened on October 9 with 1 in 15 of India’s online shoppers visiting Flipkart in the first hour. Over the 11 days that followed, about 9 in 10 of them did, with unique visitors up nearly 10% on last year. Orders, units and buyers each grew by about 20%-22% over last year.
The growth cut across cities, age groups and categories. Nearly half of buyers were Gen Z, about 60% came from Tier 2-plus cities, and Beauty, Grooming and General Merchandise buyers rose 40%. 
What India bought:
Beauty, Grooming and General Merchandise buyers rose 40% and Lifestyle buyers rose 12.5%. Large Appliances grew 30% year on year in the opening hour, and demand for big-ticket items ran at nearly 9 times a normal period through the sale. The festive basket spanned everyday self-care, fashion and big upgrades.
New customers on Flipkart Minutes rose 1.7 times compared with regular days. Chhatrapati Sambhajinagar, Nagpur, Jabalpur and Meerut were among the fastest-growing Tier 2-plus markets, and customers bought well beyond daily essentials, including laptops, gaming tablets and air fryers.
Sellers and MSMEs:
31% of transacting sellers saw 2X growth over business as usual during the sale. Sellers from Tier 2-plus markets grew 2.15 times, with Bhiwadi, Panipat, Tirupur and Hisar growing 2.6 times, 2.5 times, 2.1 times and 2 times respectively.
The opening hour showed how deeply festive shopping online has taken root in India. Eleven days later, that has held across cities, categories and sellers.
About the Flipkart Group
The Flipkart Group is one of India’s leading digital commerce entities with a strong technology-first foundation and includes group companies Flipkart, Myntra, Flipkart Wholesale, Cleartrip, and super.money. Established in 2007, Flipkart has enabled millions of sellers, merchants, and small businesses to participate in India's digital commerce revolution. With a registered user base of more than 500 million, Flipkart’s marketplace offers over 150 million products across 80+ categories. Today, there are over 1.4 million sellers on the platform, including Shopsy sellers. With a focus on empowering and delighting every Indian by delivering value through technology and innovation, Flipkart has pioneered services such as Cash on Delivery, No Cost EMI, Easy Returns, and UPI payments. Beyond shopping, Flipkart continues to create jobs, empower entrepreneurs, and strengthen India’s digital economy.